piribedil has been researched along with Macular Degeneration in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perdriel, G | 1 |
| Chevaleraud, JP | 1 |
| Decroix, G | 1 |
1 other study available for piribedil and Macular Degeneration
| Article | Year |
|---|---|
[Value of piribedil in the treatment of degenerative retinal vasculopathies].
Topics: Adult; Aged; Arteriosclerosis; Choroid; Drug Evaluation; Follow-Up Studies; Humans; Long-Term Care; | 1974 |